-
Atkins M, Hunt C M, Brown N. Clinical significance of YMDD mutant hepatitis B virus in large cohort of lamivudine-treated hepatitis B patients[J]. He-patology, 1998, 28(): A319-.
-
Clarke B, Bloor S. Molecular genotyping of hepatitis B virus[J]. J Clin Virol, 2002, 25(Suppl 3): S41-45.
-
Dienstag J L, Schiff E R, Wright T L. Lamivudine as initial treatment for chronic hepatitis B in the United States[J]. N Engl J Med, 1999, 341(): 1256-1263. doi: 10.1056/NEJM199910213411702
-
Günther S, Li B C, Miska S. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients[J]. J Virol, 1995, 69(): 5437-5444.
-
Gutfreund K S, Williams M, George R. Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance[J]. J Hepatol, 2000, 33(): 469-475. doi: 10.1016/S0168-8278(00)80284-6
-
Lai C L, Chien R N, Leung N W. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group[J]. N Engl J Med, 1998, 339(): 61-68. doi: 10.1056/NEJM199807093390201
-
Lai C L, Dienstag J, Schiff E. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B[J]. Clin Infect Dis, 2003, 36(): 687-696. doi: 10.1086/cid.2003.36.issue-6
-
Leung N W, Lai C L, Chang T T. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy[J]. Hepatology, 2001, 33(): 1527-1532. doi: 10.1053/jhep.2001.25084
-
Locarnini S. Molecular virology of hepatitis B virus[J]. Semin Liver Dis, 2004, 24(Suppl 1): 3-10.
-
Maynard J E. 1990. Hepatitis B: global importance and need for control. Vaccine, 8 Suppl: S18-20; discussion S21-23.
-
Moraleda G, Saputelli J, Aldrich C E. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus[J]. J Virol, 1997, 71(): 9392-9399.
-
Nowak M A, Bonhoeffer S, Hill A M. Viral dynamics in hepatitis B virus infection[J]. Proc Natl Acad Sci USA, 1996, 93(): 4398-4402. doi: 10.1073/pnas.93.9.4398
-
Ohishi W, Chayama K. Rare quasispecies in the YMDD motif of hepatitis B virus detected by polymerase chain reaction with peptide nucleic acid clamping[J]. Intervirology, 2003, 46(): 355-361. doi: 10.1159/000074992
-
Ou Z Y, Liu N, Chen C J. Rapid and accurate genotyping of YMDD motif variants in the hepatitis B virus genome by an improved reverse dot blot method[J]. J Clin Microbiol, 2005, 43(): 5685-5689. doi: 10.1128/JCM.43.11.5685-5689.2005
-
Su Q, Fu Y, Liu Y F. Laminin induces the expression of cytokeratin 19 in hepatocellular carcinoma cells growing in culture[J]. World J Gastroenterol, 2003, 9(): 921-929. doi: 10.3748/wjg.v9.i5.921
-
Yan J C, Ma J Y, Pan B R. The study of chronic hepatitis B in China[J]. World Chin J Digestol, 2001, 9(): 611-616.
-
Zeuzem S, de Man R A, Honkoop P. Dynamics of hepatitis B virus infection in vivo[J]. J Hepatol, 1997, 27(): 431-436. doi: 10.1016/S0168-8278(97)80345-5
-
Zoulim F. Detection of hepatitis B virus resistance to antivirals[J]. J Clin Virol, 2001, 21(): 243-253. doi: 10.1016/S1386-6532(00)00167-0